Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Saved in:
| Title: | Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. |
|---|---|
| Authors: | Chen B; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA., Nagai S; Translational Research Center, The University of Tokyo Hospital, Tokyo, Japan., Armitage JO; University of Nebraska School of Medicine, Omaha, Nebraska, USA., Witherspoon B; College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Nabhan C; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Godwin AC; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Yang YT; Center for Health Policy and Media Engagement, George Washington University, Washington, D.C., USA., Kommalapati A; School of Medicine, University of South Carolina, Columbia, South Carolina, USA., Tella SH; School of Medicine, University of South Carolina, Columbia, South Carolina, USA., DeAngelis C; Sunnybrook Health Sciences Center, Toronto, Ontario, Canada., Raisch DW; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA., Sartor O; Tulane University School of Medicine, New Orleans, Louisiana, USA., Hrushesky WJ; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., Ray PS; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Yarnold PR; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Love BL; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Norris LB; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Knopf K; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.; Alameda Health System, Oakland, California, USA., Bobolts L; Oncology Analytics Inc., Plantation, Florida, USA.; Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida, USA., Riente J; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA., Luminari S; Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy., Kane RC; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Hoque S; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA., Bennett CL; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA bennettc@cop.sc.edu.; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA. |
| Source: | The oncologist [Oncologist] 2019 Apr; Vol. 24 (4), pp. 537-548. Date of Electronic Publication: 2019 Mar 06. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1634/theoncologist.2018-0341 |
